Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Resuscitation | 17 | 2019 | 56 | 3.150 |
Why?
|
| Balloon Occlusion | 15 | 2019 | 29 | 2.800 |
Why?
|
| Hemorrhage | 8 | 2019 | 91 | 1.700 |
Why?
|
| Wounds and Injuries | 5 | 2018 | 250 | 1.450 |
Why?
|
| Appendicitis | 4 | 2013 | 13 | 1.450 |
Why?
|
| Aorta | 11 | 2019 | 103 | 1.430 |
Why?
|
| Appendectomy | 4 | 2013 | 15 | 1.380 |
Why?
|
| Blood Transfusion | 3 | 2018 | 64 | 1.260 |
Why?
|
| Shock, Hemorrhagic | 11 | 2019 | 23 | 1.230 |
Why?
|
| Military Medicine | 3 | 2018 | 22 | 1.160 |
Why?
|
| Specialties, Surgical | 2 | 2018 | 24 | 1.160 |
Why?
|
| Liver | 4 | 2017 | 464 | 1.080 |
Why?
|
| Disease Models, Animal | 14 | 2019 | 980 | 1.020 |
Why?
|
| Afghan Campaign 2001- | 4 | 2018 | 12 | 0.930 |
Why?
|
| Swine | 15 | 2019 | 201 | 0.890 |
Why?
|
| Child | 14 | 2019 | 2219 | 0.850 |
Why?
|
| Aorta, Thoracic | 5 | 2019 | 72 | 0.790 |
Why?
|
| Injury Severity Score | 2 | 2018 | 115 | 0.750 |
Why?
|
| Hospitals, Military | 3 | 2017 | 7 | 0.710 |
Why?
|
| Child, Preschool | 10 | 2019 | 1167 | 0.710 |
Why?
|
| Hemodynamics | 9 | 2018 | 148 | 0.700 |
Why?
|
| Hospitals, Pediatric | 3 | 2013 | 45 | 0.660 |
Why?
|
| Critical Care | 4 | 2019 | 114 | 0.650 |
Why?
|
| Blood Pressure | 6 | 2019 | 806 | 0.640 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2017 | 68 | 0.630 |
Why?
|
| Hemoperitoneum | 1 | 2017 | 4 | 0.620 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2017 | 871 | 0.620 |
Why?
|
| Plasma | 1 | 2017 | 15 | 0.620 |
Why?
|
| Platelet Transfusion | 1 | 2017 | 16 | 0.620 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 50 | 0.620 |
Why?
|
| Burns | 4 | 2014 | 97 | 0.610 |
Why?
|
| Erythrocyte Transfusion | 1 | 2017 | 32 | 0.610 |
Why?
|
| Adolescent | 12 | 2018 | 3255 | 0.590 |
Why?
|
| Retrospective Studies | 13 | 2019 | 3112 | 0.570 |
Why?
|
| Female | 26 | 2019 | 18173 | 0.550 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 33 | 0.550 |
Why?
|
| Male | 25 | 2019 | 17815 | 0.540 |
Why?
|
| Reperfusion Injury | 4 | 2019 | 43 | 0.520 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2017 | 78 | 0.520 |
Why?
|
| Animals | 19 | 2019 | 7300 | 0.510 |
Why?
|
| Pediatrics | 2 | 2015 | 132 | 0.510 |
Why?
|
| Hypertension | 2 | 2019 | 910 | 0.500 |
Why?
|
| Direct Service Costs | 1 | 2013 | 2 | 0.480 |
Why?
|
| Plasma Exchange | 2 | 2013 | 10 | 0.470 |
Why?
|
| Gastroplasty | 1 | 2012 | 11 | 0.420 |
Why?
|
| Fundoplication | 1 | 2012 | 8 | 0.420 |
Why?
|
| Vomiting | 1 | 2012 | 24 | 0.420 |
Why?
|
| Humans | 24 | 2019 | 29123 | 0.420 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 25 | 0.410 |
Why?
|
| Laparoscopy | 1 | 2013 | 169 | 0.410 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 153 | 0.400 |
Why?
|
| Registries | 3 | 2018 | 278 | 0.400 |
Why?
|
| Cholelithiasis | 1 | 2011 | 10 | 0.400 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2011 | 12 | 0.390 |
Why?
|
| Infant | 6 | 2019 | 969 | 0.390 |
Why?
|
| Ethnic Groups | 1 | 2013 | 440 | 0.390 |
Why?
|
| Endosonography | 1 | 2011 | 56 | 0.380 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 71 | 0.380 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 74 | 0.380 |
Why?
|
| Bioprosthesis | 1 | 2011 | 55 | 0.370 |
Why?
|
| Empyema, Pleural | 1 | 2009 | 6 | 0.350 |
Why?
|
| Mediastinitis | 1 | 2009 | 7 | 0.350 |
Why?
|
| Branchial Region | 1 | 2009 | 4 | 0.350 |
Why?
|
| Shock | 1 | 2009 | 28 | 0.340 |
Why?
|
| Referral and Consultation | 5 | 2014 | 113 | 0.340 |
Why?
|
| Tissue Engineering | 2 | 2012 | 608 | 0.340 |
Why?
|
| Infant, Newborn | 4 | 2018 | 599 | 0.290 |
Why?
|
| Stents | 2 | 2017 | 171 | 0.270 |
Why?
|
| Length of Stay | 3 | 2019 | 292 | 0.260 |
Why?
|
| Hospital Mortality | 2 | 2017 | 186 | 0.260 |
Why?
|
| Postoperative Complications | 3 | 2015 | 670 | 0.250 |
Why?
|
| Treatment Outcome | 8 | 2019 | 3101 | 0.240 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 2109 | 0.230 |
Why?
|
| Burn Units | 3 | 2014 | 27 | 0.220 |
Why?
|
| Random Allocation | 3 | 2017 | 213 | 0.220 |
Why?
|
| United States | 3 | 2015 | 3632 | 0.210 |
Why?
|
| Time Factors | 4 | 2019 | 2001 | 0.200 |
Why?
|
| Preoperative Care | 2 | 2012 | 110 | 0.190 |
Why?
|
| Hemostatic Techniques | 2 | 2018 | 7 | 0.190 |
Why?
|
| Endothelial Cells | 2 | 2012 | 179 | 0.190 |
Why?
|
| Endocrine System | 1 | 2019 | 1 | 0.180 |
Why?
|
| Afghanistan | 2 | 2016 | 5 | 0.170 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 83 | 0.170 |
Why?
|
| Cold Temperature | 1 | 2018 | 39 | 0.160 |
Why?
|
| Vascular Patency | 3 | 2017 | 66 | 0.160 |
Why?
|
| Prosthesis Design | 3 | 2017 | 87 | 0.160 |
Why?
|
| Polytetrafluoroethylene | 1 | 2017 | 12 | 0.160 |
Why?
|
| Lower Extremity | 1 | 2018 | 94 | 0.150 |
Why?
|
| Iliac Artery | 1 | 2017 | 46 | 0.150 |
Why?
|
| Forecasting | 1 | 2018 | 133 | 0.150 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 96 | 0.150 |
Why?
|
| Feasibility Studies | 2 | 2015 | 263 | 0.150 |
Why?
|
| Traumatology | 1 | 2016 | 14 | 0.150 |
Why?
|
| Cause of Death | 1 | 2017 | 220 | 0.140 |
Why?
|
| Aneurysm, Ruptured | 1 | 2016 | 26 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2016 | 34 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2012 | 1306 | 0.140 |
Why?
|
| Chest Tubes | 1 | 2015 | 6 | 0.140 |
Why?
|
| Hemothorax | 1 | 2015 | 6 | 0.140 |
Why?
|
| Altruism | 1 | 2015 | 7 | 0.140 |
Why?
|
| Drainage | 1 | 2015 | 49 | 0.130 |
Why?
|
| Neurosurgical Procedures | 2 | 2019 | 98 | 0.130 |
Why?
|
| Femoral Artery | 2 | 2016 | 44 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 709 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 157 | 0.130 |
Why?
|
| Radiation Effects | 2 | 2012 | 4 | 0.130 |
Why?
|
| Disease Progression | 1 | 2017 | 572 | 0.130 |
Why?
|
| Lactic Acid | 2 | 2018 | 52 | 0.130 |
Why?
|
| Pulsatile Flow | 2 | 2012 | 25 | 0.130 |
Why?
|
| Bioreactors | 2 | 2012 | 59 | 0.120 |
Why?
|
| Reperfusion | 3 | 2018 | 17 | 0.120 |
Why?
|
| Sheep | 2 | 2012 | 221 | 0.120 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 8 | 0.120 |
Why?
|
| Hemofiltration | 1 | 2013 | 3 | 0.120 |
Why?
|
| California | 1 | 2013 | 60 | 0.120 |
Why?
|
| Renal Replacement Therapy | 1 | 2013 | 16 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 532 | 0.120 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 88 | 0.110 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2013 | 55 | 0.110 |
Why?
|
| Acute Disease | 1 | 2013 | 239 | 0.110 |
Why?
|
| Jugular Veins | 1 | 2012 | 26 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2012 | 799 | 0.110 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2012 | 45 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2012 | 97 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 391 | 0.110 |
Why?
|
| Dogs | 1 | 2012 | 117 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 15 | 0.100 |
Why?
|
| Regional Medical Programs | 1 | 2011 | 4 | 0.100 |
Why?
|
| Technetium Tc 99m Lidofenin | 1 | 2011 | 3 | 0.100 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cholagogues and Choleretics | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cholangiography | 1 | 2011 | 6 | 0.100 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2011 | 7 | 0.100 |
Why?
|
| False Negative Reactions | 1 | 2011 | 21 | 0.100 |
Why?
|
| Ceftriaxone | 1 | 2011 | 11 | 0.100 |
Why?
|
| Tissue Scaffolds | 2 | 2012 | 386 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 29 | 0.100 |
Why?
|
| Pneumonia, Bacterial | 1 | 2011 | 31 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2011 | 18 | 0.100 |
Why?
|
| Actins | 1 | 2011 | 52 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 35 | 0.100 |
Why?
|
| Cross Infection | 1 | 2011 | 46 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2011 | 40 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2011 | 74 | 0.100 |
Why?
|
| Age of Onset | 1 | 2011 | 95 | 0.100 |
Why?
|
| Bacteria | 1 | 2011 | 45 | 0.100 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 37 | 0.100 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 113 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 293 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 62 | 0.090 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 86 | 0.090 |
Why?
|
| Aged | 6 | 2016 | 9492 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 666 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2011 | 454 | 0.090 |
Why?
|
| Hospitalization | 2 | 2011 | 417 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2011 | 1688 | 0.090 |
Why?
|
| Young Adult | 3 | 2016 | 2402 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2012 | 260 | 0.090 |
Why?
|
| Middle Aged | 6 | 2016 | 10834 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 525 | 0.090 |
Why?
|
| Hydropneumothorax | 1 | 2009 | 3 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2009 | 27 | 0.090 |
Why?
|
| Rupture, Spontaneous | 1 | 2009 | 18 | 0.090 |
Why?
|
| Logistic Models | 1 | 2011 | 727 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2010 | 110 | 0.090 |
Why?
|
| Electrocoagulation | 1 | 2009 | 12 | 0.090 |
Why?
|
| Comorbidity | 1 | 2011 | 540 | 0.090 |
Why?
|
| Laryngoscopy | 1 | 2009 | 39 | 0.080 |
Why?
|
| Salvage Therapy | 1 | 2009 | 118 | 0.080 |
Why?
|
| Urine | 1 | 2009 | 59 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 285 | 0.080 |
Why?
|
| Ischemia | 2 | 2019 | 92 | 0.080 |
Why?
|
| Adult | 5 | 2016 | 8426 | 0.080 |
Why?
|
| Age Factors | 1 | 2011 | 1108 | 0.080 |
Why?
|
| Risk Factors | 1 | 2015 | 3537 | 0.070 |
Why?
|
| Survival Rate | 2 | 2017 | 795 | 0.060 |
Why?
|
| North Carolina | 3 | 2014 | 1423 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2015 | 469 | 0.050 |
Why?
|
| Patient Selection | 2 | 2016 | 257 | 0.050 |
Why?
|
| Aldosterone | 1 | 2019 | 28 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 30 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2019 | 51 | 0.040 |
Why?
|
| Perfusion | 1 | 2019 | 64 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 129 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2019 | 61 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2018 | 10 | 0.040 |
Why?
|
| Myoglobin | 1 | 2018 | 11 | 0.040 |
Why?
|
| Hypothermia | 1 | 2018 | 12 | 0.040 |
Why?
|
| Homeostasis | 1 | 2019 | 127 | 0.040 |
Why?
|
| Renin | 1 | 2019 | 112 | 0.040 |
Why?
|
| Hindlimb | 1 | 2018 | 57 | 0.040 |
Why?
|
| Muscles | 1 | 2018 | 53 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 195 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 59 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2019 | 279 | 0.040 |
Why?
|
| Angiography | 1 | 2017 | 75 | 0.040 |
Why?
|
| Breast Diseases | 1 | 2016 | 4 | 0.040 |
Why?
|
| Aneurysm, False | 1 | 2016 | 13 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 49 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 68 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2016 | 44 | 0.040 |
Why?
|
| Equipment Design | 1 | 2016 | 167 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 440 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 26 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2012 | 5 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 18 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2012 | 17 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2012 | 21 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 42 | 0.030 |
Why?
|
| Punctures | 1 | 2012 | 32 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 41 | 0.030 |
Why?
|
| Needles | 1 | 2012 | 28 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 82 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 90 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 43 | 0.030 |
Why?
|
| Materials Testing | 1 | 2012 | 84 | 0.030 |
Why?
|
| Models, Animal | 1 | 2012 | 160 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 165 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 203 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 462 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 374 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 863 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 3719 | 0.010 |
Why?
|